Ophthalmology
(OPHTHALMOLOGY) 《眼科学》

2015年影响因子
6.75
- 2013-08-09•ANCHOR、MARINA和HORIZON试验中经兰尼单抗治疗患者的7年结局评估
- 2013-08-09•兰尼单抗治疗糖尿病性黄斑水肿的长期结局:RISE和RIDE两项III期临床试验的36个月结果
- 2013-08-09•地塞米松植入剂联合激光凝固治疗在弥散性糖尿病性黄斑水肿中的应用
- 2013-08-09•兰尼单抗0.5 mg治疗糖尿病性黄斑水肿2年的安全性和疗效:RESTORE扩展研究的中期分析
- 2012-07-25•住院医师参与白内障手术对手术时间和费用的影响
- 2012-06-06•采用针灸纠正屈光参差性弱视患者的屈光状态的附加效应:一项随机交叉试验的1年结果
- 2013-10-22•超声乳化白内障吸除术和小梁切除术对药物不能控制且未发生白内障的慢性闭角型青光眼的效果比较
- 2012-07-30•急诊部护理执业人员获取的非瞳孔放大数字眼底成像质量:FOTO-ED研究
- 2012-07-30•视野:一项雷珠单抗治疗继发于年龄相关黄斑变性脉络膜新生血管形成的开放标签延伸试验
- 2012-07-30•使用雷珠单抗和贝伐单抗治疗新生性年龄相关黄斑变性:两年研究结果
- 2015-11-16•豹纹状眼底:流行病学及相关因素:2011北京眼科研究
- 2015-11-06•遗传变异体与息肉状脉络膜血管病变之间的关系:一项系统评价和meta分析更新
- 2015-11-06•学龄期儿童弱视患病率及随年龄、性别和种族而发生的变化:一项多国参与的屈光不正的相关研究
- 2015-10-27•在青光眼检测视野缺损发生之前使用光学相干断层成像术估计提前期
- 2015-10-27•与急性眼压升高相关的急性乳头周围视网膜色素上皮细胞改变
- 2014-05-27•一项多国研究中的可纠正性和非可纠正性近视损害的年龄相关性患病率和需求满足
最新一期
Article Title | Author(s) | Pages | ||
---|---|---|---|---|
Editorial Board
|
A2 | |||
This Issue at a Glance | ||||
Article Title | Author(s) | Pages | ||
This Issue At A Glance
|
Lori Baker Schena, John Kerrison | A7 | ![]() |
|
A Simple Vista en Este Número
|
Lori Baker Schena, John Kerrison | e1-e2 | ![]() ![]() |
|
This Issue At A Glance
|
由Lori Baker Schena, 并且John Kerrison | e3 | ![]() ![]() |
|
Contents
|
A11 | |||
Editorial | ||||
Article Title | Author(s) | Pages | ||
Taking TASS to Task
|
John D. Gottsch, Oliver D. Schein | 1295-1296 | ||
Original Articles | ||||
Translational Science Review | ||||
Article Title | Author(s) | Pages | ||
The Food and Drug Administration's Proactive Toxic Anterior Segment Syndrome Program
|
Malvina B. Eydelman, Michelle E. Tarver, Don Calogero, Shelley Y. Buchen, et al. | 1297-1302 | ||
Keratoplasty for Corneal Endothelial Disease, 2001–2009
|
Roni M. Shtein, Duna Raoof-Daneshvar, Hsien-Chang Lin, Alan Sugar,et al. | 1303-1310 | ||
Indications, Outcomes, and Risk Factors for Failure in Tectonic Keratoplasty
|
Marcus Ang, Jodhbir S. Mehta, Chelvin C.A. Sng, Hla Myint Htoon,et al. | 1311-1319 | ||
Association of Single Nucleotide Polymorphisms of Interleukins-1β, -6, and -12B with Contact Lens Keratitis Susceptibility and Severity
|
Nicole A. Carnt, Mark D.P. Willcox, Scott Hau, Linda L. Garthwaite, et al. | 1320-1327 | ||
Tofacitinib (CP-690,550), a Janus Kinase Inhibitor for Dry Eye Disease: Results from a Phase 1/2 Trial
|
Shiao Hui (Melissa) Liew, Kelly K. Nichols, Karen J. Klamerus, Jim Z. Li, et al. | 1328-1335 | ||
Ocular Trauma Score: A Useful Predictor of Visual Outcome at Six Weeks in Patients with Traumatic Cataract
|
Mehul A. Shah, Shreya M. Shah, Adway Applewar, Chintan Patel, et al. | 1336-1341 | ||
Regional Variations and Trends in the Prevalence of Diagnosed Glaucoma in the Medicare Population
|
Sandra D. Cassard, Harry A. Quigley, Emily W. Gower, David S. Friedman, et al. | 1342-1351 | ||
Fear of Falling and Visual Field Loss from Glaucoma
|
Pradeep Y. Ramulu, Suzanne W. van Landingham, Robert W. Massof, Emilie S. Chan, et al. | 1352-1358 | ||
Reversal of Lamina Cribrosa Displacement and Thickness after Trabeculectomy in Glaucoma
|
Eun Ji Lee, Tae-Woo Kim, Robert N. Weinreb | 1359-1366 | ||
The Development of a Decision Analytic Model of Changes in Mean Deviation in People with Glaucoma: The COA Model
|
Steven M. Kymes, Dennis L. Lambert, Paul P. Lee, David C. Musch, et al. | 1367-1374 | ||
Visual Symptoms and Retinal Straylight after Laser Peripheral Iridotomy: The Zhongshan Angle-Closure Prevention Trial
|
Nathan Congdon, Xixi Yan, David S. Friedman, Paul J. Foster, et al. | 1375-1382 | ||
Changes in Anterior Segment Morphology after Laser Peripheral Iridotomy: An Anterior Segment Optical Coherence Tomography Study
|
Alicia C. How, Mani Baskaran, Rajesh S. Kumar, Mingguang He, et al. | 1383-1387 | ||
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: Two-Year Results
|
Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, Daniel F. Martin, Maureen G. Maguire, Stuart L. Fine, et al. | 1388-1398 | ![]() |
|
Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration: One-Year Findings from the IVAN Randomized Trial
|
The IVAN Study Investigators, Usha Chakravarthy, Simon P. Harding, Chris A. Rogers, et al. | 1399-1411 | ||
Hyporeflective Wedge-Shaped Band in Geographic Atrophy Secondary to Age-related Macular Degeneration: An Underreported Finding
|
Jordi Monés, Marc Biarnés, Fabio Trindade | 1412-1419 | ||
Changes in Antibiotic Resistance Patterns of Conjunctival Flora Due to Repeated Use of Topical Antibiotics after Intravitreal Injection
|
Eugene Milder, James Vander, Chirag Shah, Sunir Garg | 1420-1424 | ||
Macular Epiretinal Brachytherapy in Treated Age-related Macular Degeneration: MERITAGE Study: Twelve-Month Safety and Efficacy Results
|
Pravin U. Dugel, Robert Petrarca, Michael Bennett, Adiel Barak, et al. | 1425-1431 | ||
Risk Factors for Conversion to Neovascular Age-related Macular Degeneration Based on Longitudinal Morphologic and Visual Acuity Data
|
Thomas R. Friberg, Richard A. Bilonick, Peter M. Brennen | 1432-1437 | ||
Correlation between Length of Foveal Cone Outer Segment Tips Line Defect and Visual Acuity after Macular Hole Closure
|
Yuji Itoh, Makoto Inoue, Tosho Rii, Tomoyuki Hiraoka, et al. | 1438-1446 | ||
A Novel Noninvasive Detection Method for Retinal Nonperfusion Using Confocal Red-free Imaging
|
Yong Un Shin, Byung Ro Lee, Sungmin Kim, Won June Lee | 1447-1454 | ||
Clinical Manifestations of Human Immunodeficiency Virus-Induced Uveitis
|
Paradee Kunavisarut, Wasna Sirirungsi, Kessara Pathanapitoon, Aniki Rothova | 1455-1459 | ||
Clinical Features and Presentation of Infectious Scleritis from Herpes Viruses: A Report of 35 Cases
|
Luis Alonso Gonzalez-Gonzalez, Nicolas Molina-Prat, Priyanka Doctor, Joseph Tauber, et al. | 1460-1464 | ||
Ocular Whipple's Disease: Therapeutic Strategy and Long-Term Follow-Up
|
Valérie Touitou, Florence Fenollar, Nathalie Cassoux, Helene Merle-Beral, et al. | 1465-1469 | ||
Outcome, Pathologic Findings, and Compliance in Orbital Retinoblastoma (International Retinoblastoma Staging System Stage III) Treated with Neoadjuvant Chemotherapy: A Prospective Study
|
Venkatraman Radhakrishnan, Seema Kashyap, Neelam Pushker, Sanjay Sharma,et al. | 1470-1477 | ||
Annual Changes in Refractive Errors and Ocular Components before and after the Onset of Myopia in Chinese Children
|
Fan Xiang, Mingguang He, Ian G. Morgan | 1478-1484 | ||
Congenital Ectropion Uvea and Mechanisms of Glaucoma in Neurofibromatosis Type 1: New Insights
|
Deepak P. Edward, Jose Morales, Rachida A. Bouhenni, Jayaprakash Patil, et al. | 1485-1494 | ||
Online-only Articles | ||||
Article Title | Author(s) | Pages | ||
Rabbit Ocular Reactivity to Bacterial Endotoxin Contained in Aqueous Solution and Ophthalmic Viscosurgical Devices
|
Shelley Y. Buchen, Don Calogero, Gene Hilmantel, Malvina B. Eydelman | e4-e10 | ![]() |
|
Detecting Endotoxin Contamination of Ophthalmic Viscosurgical Devices: Intracameral versus Intravitreal Assays in Rabbits
|
Shelley Y. Buchen, Don Calogero, Gene Hilmantel, Malvina B. Eydelman | e11-e18 | ![]() |
|
Rabbit Intraocular Reactivity to Endotoxin Measured by Slit-Lamp Biomicroscopy and Laser Flare Photometry
|
Robert B. Nussenblatt, Don Calogero, Shelley Y. Buchen, Henry A. Leder, et al. | e19-e23 | ![]() |
|
Evaluation of Intraocular Reactivity to Organic Contaminants of Ophthalmic Devices in a Rabbit Model
|
Shelley Y. Buchen, Don Calogero, Michelle E. Tarver, Gene Hilmantel, et al. | e24-e29 | ![]() |
|
An Investigation of Enzymatic Detergents as a Potential Cause of Toxic Anterior Segment Syndrome
|
Henry A. Leder, Margot Goodkin, Shelley Y. Buchen, Don Calogero, et al. | e30-e35 | ![]() |
|
Evaluation of Intraocular Reactivity to Metallic and Ethylene Oxide Contaminants of Medical Devices in a Rabbit Model
|
Don Calogero, Shelley Y. Buchen, Michelle E. Tarver, Gene Hilmantel, et al. | e36-e42 | ![]() |
|
Immunomodulatory Effect of the Topical Ophthalmic Janus Kinase Inhibitor Tofacitinib (CP-690,550) in Patients with Dry Eye Disease
|
Jing-Feng Huang, Rolla Yafawi, Min Zhang, Michael McDowell, et al. | e43-e50 | ![]() |
|
Letters to the Editor | ||||
Research Correspondence | ||||
Article Title | Author(s) | Pages | ||
New Color Iris Implants
|
Rupa D. Shah, J. Bradley Randleman | 1495-1495.e2 | ![]() |
|
Positron Emission Tomography
|
Angelina Cistaro, Natale Quartuccio, Sara Vesco, Marco Pagani, et al. | 1496-1497.e1 | ![]() |
|
Choroidal Thickness After Scleral Buckling
|
Masahiro Miura, Go Arimoto, Rintaro Tsukahara, Rei Nemoto, et al. | 1497-1498 | ||
Adaptive Optics Photoreceptor Imaging
|
Marco Lombardo, Giuseppe Lombardo, Pietro Ducoli, Sebastiano Serrao | 1498-1498.e2 | ![]() |
|
General Correspondence | ||||
Article Title | Author(s) | Pages | ||
Descemet's Stripping Automated Endothelial Keratoplasty
|
Sunita Chaurasia, Muralidhar Ramappa, Harsha Laxmana Rao, Piyush Bansal | 1498-1499 | ||
Author reply
|
Jennifer Y. Li, Mark A. Terry, Jeffrey Goshe, David Davis-Boozer | 1499 | ||
Pseudoexfoliation
|
Hugh R. Taylor | 1499-1500 | ||
Author reply
|
Louis R. Pasquale, Jae Hee Kang, Stephanie Loomis, Janey L. Wiggs, et al. | 1500 | ||
Myopia and Glaucoma
|
Harry H. Mark | 1500-1501.e1 | ![]() |
|
Author reply
|
Tae-Woo Kim, Martha Kim, Robert N. Weinreb | 1501 | ||
Drusen Volume as a Study Endpoint
|
Maureen G. Maguire | 1501-1502 | ||
Author reply
|
Zohar Yehoshua, Fenghua Wang, Philip J. Rosenfeld, Fernando M. Penha, et al. | 1502 | ||
Cat Scratch Disease
|
Clare L. Fraser, Susan Sanchez, Nancy J. Newman, Valérie Biousse | 1502-1503 | ||
Author reply
|
Sulene L. Chi, Eric Eggenberger, Rod Foroozan, Karl Golnik, et al. | 1503 | ||
Intraocular Lenses in Children
|
Sumit Monga, Muralidhar Ramappa, Ramesh Kekunnaya, Sunita Chaurasia, et al. | 1503-1504 | ||
Author reply
|
David A. Plager, Michael J. Lynn, M. Edward Wilson, Edward G. Buckley, et al. | 1504-1505 | ||
Pediatric Posterior Scleritis
|
Genie M. Bang, Michael C. Brodsky | 1505-1505.e1 | ![]() |
|
Author reply
|
Chui Ming Gemmy Cheung, Soon-Phaik Chee | 1505 |
- 1
-
2015-04-01 14:04 发表郭超伟 北京协和医院 肿瘤科
《眼科学杂志》于1978年创刊,是美国眼科学会的官方刊物,由Elsevier出版社每月出版,近5年的平均影响因子为6.195分,2013年影响因子为6.170,是眼科领域同类期刊中影响因子排名第二的杂志。该杂志内容偏向临床,对实验设计的创新性、统计学方法的科学性及英文表达的准确性要求较高,主要面对眼科临床医师,其文章类型包括论著、AAO会议文章、读者来信(Correspondence)、主编约稿(Editorial)、荟萃分析以及转化医学综述。杂志稿件由国际专家严格同行评议,其编委会由近40名来自世界各地的著名眼科学专家、统计学专家及流行病学专家组成,主编为曾任Mayo Clinic首席执行官的著名眼整形专家George B. Bartley教授,值得一提的是该杂志亚洲区编委是来自中国广州中山大学中山眼科中心的青光眼专家何明光教授。 2014年8月刊中登出了一篇美国加州大学圣地亚哥分校汉密尔顿青光眼中心关于黄斑区视网膜神经节细胞(RCG)计数预测青光眼视神经损伤的研究。青光眼以RGC的功能障碍和损失为特点,应用OCT可以获得黄斑区结构的客观测量。本研究旨在评价青光眼患者黄斑区节细胞内丛状层(mGCIPL)厚度和RGC之间的关系,并比较mGCIPL厚度和预计RGC细胞数量区分健康眼和青光眼的能力,结果发现了黄斑区RGC计数和mGCIPL厚度之间的强相关性,以及黄斑区RGC计数能够更加出色的评估青光眼损伤,这提供了青光眼专家早期发现并定量评估患者视功能损伤程度的依据。 2014年9月刊中发表了一篇北京大学人民医院眼科黎晓新教授团队有关康柏西普治疗新生血管性年龄相关性黄斑变性安全性和有效性的文章,即AURORA研究2期临床的结果。康柏西普是我国独立自主研发的拥有全球知识产权的单克隆抗体新药,其临床实验对我国新药研发具有重大的开创性意义。本研究共纳入122名患者,1:1随机分组分别接受0.5mg和2.0mg康柏西普每月一次眼内注射连续3月,随后随机以原有剂量接受每月一次注射或仅在必要时接受注射,观察12个月,结果发现所有剂量组患者的最佳矫正视力均较基线水平显著提高且耐受良好,不同剂量或不同治疗方案之间并无显著差异,说明康柏西普治疗新生血管性年龄相关性黄斑变性具有非常好的前景。当然,还需要3期临床实验的进一步验证。 2014年10月刊中发表一篇有关地塞米松玻璃体腔植入剂治疗糖尿病黄斑水肿(DME)的随机、安慰剂对照、为期三年的临床实验结果。该地塞米松玻璃体腔植入剂(Ozurdex)是一种可生物降解的植入剂,它被放置于眼睛后段的玻璃体腔内,被称为Novadur的专有固体聚合物长效系统的释放地塞米松注射液,是目前治疗黄斑水肿的新型药物类型,其适应症方面的临床实验结果具有重要的指导意义。该临床实验是由来自美国加州大学洛杉矶分校的David S. Boyer教授团队进行,其研究结果发现0.7mg和0.35mg的Ozurdex在三年内分别平均注射4.1和4.4次,均至少提高患者视力15个字母,与安慰剂组相比均具有显著差异,且未发生严重不良事件,说明Ozurdex治疗DME安全有效,有望在不久的将来应用于临床,造福更多黄斑水肿患者。 2014年11月刊中登出了我国著名葡萄膜炎专家杨培增教授团队有关原田小柳病(VKH)和白塞病(BD)遗传学方面的研究成果。原田小柳病和白塞病均是好发于东亚地区的葡萄膜炎疾病,在我国发病率较高,了解其发病的遗传学机制具有重要的临床意义。杨培增教授是我国葡萄膜炎领域的领军人物,拥有极其丰富的临床病例资料,其领导的团队研究结果指出IL17F和IL23A的高拷贝数量与BD和VKH发病有关,而IL17F蛋白表达的增强 以及外周血单核细胞的增殖与IL17F高拷贝数量有关。 2014年11月刊上还登出了一篇著名角膜病专家Jonathan H. Lass教授团队关于供体糖尿病是否影响角膜移植成功率的文章。随着全球糖尿病患者的增加,器官移植供体人群也发生变化,供体糖尿病病史是否影响器官在受体中的状态成为我们重点关心的问题。该研究为一项多中心、前瞻性、双盲、对照的临床研究,纳入美国80个临床中心的1090例穿透性角膜移植患者,关于供体和受体的糖尿病病情从医疗记录中获得,主要观察结果为移植失败时间和角膜内皮计数(ECD)。结果发现供体糖尿病病史与移植失败率、基线ECD、术后10年ECD和10年来ECD的变化均无显著关联。该研究并未发现供体糖尿病病史与穿透性角膜移植预后的关系。然而,该研究中对供体的糖尿病病情评估仅基于病历数据,是不精确的。因此,进一步探索供体糖尿病对角膜移植术后角膜内皮的影响还需要更多、更精确的评估糖尿病及其并发症状态的研究。 《眼科学》(Ophthalmology)杂志主要发表国际性多中心临床实验结果、具有开创意义的临床研究文章及大规模的流行病学研究成果,主要面向眼科专业人员,是眼科领域的权威杂志。 来源:医科院图书馆《国外医学新书评介》